A recent report shows that including dogs with cancer in studies of oncology drugs can speed the drug development process.
Including dogs with cancer in studies of oncology drugs can speed the drug development process, according to a recently published report from the National Academy of Medicine’s Workshop on Comparative Oncology. Tapping the potential of comparative oncology, a branch of research that studies cancer across species, can improve therapeutic options for both dogs and people.
“We are hopeful this analysis will be useful in developing and advancing an agenda for the field of comparative oncology,” said Dr. Jeffrey Trent, one of the study authors, in a press release. “Many canine breeds develop naturally occurring cancers, such as breast cancer and melanoma, that share remarkable genetic similarities with their human equivalent.”
Scientists at the workshop discussed gaps in comparative oncology research. Conclusions from workshop sessions include the following:
Dr. Laurie Anne Walden received her doctorate in veterinary medicine from North Carolina State University in 1994. After an internship at Auburn University College of Veterinary Medicine, she returned to North Carolina, where she has been in companion animal general practice for over 20 years. Dr. Walden is also a board-certified Editor in the Life Sciences and owner of Walden Medical Writing.